Fewer, But Larger, Local Bioscience Funding Deals
Acelyrin Buys Maryland Immunotherapy Firm
Execs Hired At Acelyrin
Acelyrin Raises $300M to Further Growth
TriMed Reaches End Stage In Deal with Henry Schein
Business Events Calendar
Setpoint Gets Breakthrough FDA Rulings
Loop Tries Out a New (Interim) CEO
Enhance Your Business’ Sustainability with LADWP Programs